Cargando…

Al(18)F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography Imaging

Positron emission tomography (PET) using radiolabeled biomolecules is a translational molecular imaging technology that is increasingly used in support of drug development. Current methods for radiolabeling biomolecules with fluorine-18 are laborious and require multistep procedures with moderate la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cleeren, Frederik, Lecina, Joan, Ahamed, Muneer, Raes, Geert, Devoogdt, Nick, Caveliers, Vicky, McQuade, Paul, Rubins, Daniel J, Li, Wenping, Verbruggen, Alfons, Xavier, Catarina, Bormans, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562226/ https://www.ncbi.nlm.nih.gov/pubmed/28824726 http://dx.doi.org/10.7150/thno.20094

Ejemplares similares

Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging
por: Bridoux, Jessica, et al.
Publicado: (2020)

Micro-flow photosynthesis of new dienophiles for inverse-electron-demand Diels–Alder reactions. Potential applications for pretargeted in vivo PET imaging
por: Billaud, Emilie M. F., et al.
Publicado: (2017)

Synthesis, Biodistribution and In vitro Evaluation of Brain Permeable High Affinity Type 2 Cannabinoid Receptor Agonists [(11)C]MA2 and [(18)F]MA3
por: Ahamed, Muneer, et al.
Publicado: (2016)

Characterization of neuroinflammatory positron emission tomography biomarkers in chronic traumatic encephalopathy
por: Varlow, Cassis, et al.
Publicado: (2022)

Comparison of New Tau PET-Tracer Candidates With [(18)F]T808 and [(18)F]T807
por: Declercq, Lieven, et al.
Publicado: (2016)

Radiopharmaceuticals for Cancer Imaging and Therapy
por: Bormans, Guy, et al.
Publicado: (2023)

Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
por: D’Huyvetter, Matthias, et al.
Publicado: (2014)

Anti-Human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation
por: Bridoux, Jessica, et al.
Publicado: (2020)

(68)Ga-Labeling: Laying the Foundation for an Anti-Radiolytic Formulation for NOTA-sdAb PET Tracers
por: Baudhuin, Henri, et al.
Publicado: (2021)

Phase I Study of [(68)Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)
por: Gondry, Odrade, et al.
Publicado: (2023)

Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide–Cysteine Chemistry
por: Chigoho, Dora Mugoli, et al.
Publicado: (2021)

Targeted Radionuclide Therapy with A (177)Lu-labeled Anti-HER2 Nanobody
por: D'Huyvetter, Matthias, et al.
Publicado: (2014)

An open-label, positron emission tomography study of the striatal D(2)/D(3) receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants
por: Wong, Dean F., et al.
Publicado: (2020)

Correction to: An open-label, positron emission tomography study of the striatal D(2)/D(3) receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants
por: Wong, Dean F., et al.
Publicado: (2021)

Radiosynthesis and Early Evaluation of a Positron Emission Tomography Imaging Probe [(18)F]AGAL Targeting Alpha-Galactosidase A Enzyme for Fabry Disease
por: Lohith, Talakad G., et al.
Publicado: (2023)

Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
por: Declercq, Lieven D., et al.
Publicado: (2016)

D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy
por: Luyten, Kaat, et al.
Publicado: (2021)

Immunogenicity Risk Profile of Nanobodies
por: Ackaert, Chloé, et al.
Publicado: (2021)

Automated GMP compliant production of [(18)F]AlF-NOTA-octreotide
por: Tshibangu, Térence, et al.
Publicado: (2020)

Positron emission tomography
Publicado: (1995)

Positron Emission Tomography
por: Piepmeier, Joseph M.
Publicado: (1986)

Positron emission tomography
por: Paans, A M J
Publicado: (2006)

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside
por: Ahenkorah, Stephen, et al.
Publicado: (2021)

Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy
por: Broos, Katrijn, et al.
Publicado: (2018)

Osteoarthritis of the Knee
por: McQuade, Jean
Publicado: (2015)

Compulsory Health Insurance
por: McQuade, Jerry
Publicado: (1920)

Positron emission tomography: An overview
por: Shukla, A. K., et al.
Publicado: (2006)

Scintillators for positron emission tomography
por: Moses, W W, et al.
Publicado: (1995)

Detectors in positron emission tomography
por: Zatcepin, Artem, et al.
Publicado: (2022)

Radiochemistry for positron emission tomography
por: Rong, Jian, et al.
Publicado: (2023)

Digit ratio links prenatal hormone exposure with adult lung function
por: McQuade, Denise Brooks
Publicado: (2014)

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
por: Therriault, Joseph, et al.
Publicado: (2022)

Positron emission tomography: clinical practice
por: Valk, Peter E, et al.
Publicado: (2006)

Positron emission tomography in uro-oncology
por: Hain, S F
Publicado: (2005)

The applications of positron emission tomography to oncology.
por: Ott, R. J.
Publicado: (1991)

Positron emission tomography imaging of dementia
por: Small, Gary W.
Publicado: (2000)

Positron emission tomography in breast disease
por: Sharma, B
Publicado: (2008)

Positron emission tomography: basic sciences
por: Bailey, D L, et al.
Publicado: (2003)

Study of a Positron Emission Mammograph
por: Trummer, J
Publicado: (2007)

positron emission tomography in neuroscience research
por: Vanitha, N.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_44uakuhlmom7dc2kqohmtovvrk